Instrumentation first-half loss blamed on pricing pressures
This article was originally published in Clinica
Executive Summary
Declining margins in haemostasis products in Europe and pricing pressures generally led to a Lit10.9 billion ($5 million) first-half loss at Instrumentation Laboratory. This is despite sales growth from acquisitions by Italian diagnostics company running at more than 10%,